Psilocybin & Psychedelic Criminal Defense in Washington

A Washington psilocybin prosecution raised unresolved questions about medical necessity, religious freedom, and constitutional rights. Attorney Nicole T. Dalton reflects on the case and the evolving law surrounding psychedelics.

Psilocybin & Psychedelic Criminal Defense in Washington

The Unfinished Questions of Religious Freedom and Psilocybin

In May 2024, the United States Government Accountability Office published a report with a remarkable title: DEA Should Improve Its Religious Exemptions Petition Process for Psilocybin (Mushrooms) and Other Controlled Substances, GAO-24-106630.

Psilocybin & Psychedelic Criminal Defense in Washington

The report examined the federal Drug Enforcement Administration’s process for evaluating religious exemptions under the Religious Freedom Restoration Act (RFRA). Among its findings, GAO reported that, from fiscal year 2016 through January 2024, DEA had received 24 religious-exemption petitions involving controlled substances. None had been granted through that petition process during the reporting period. Six involved psilocybin; three had been withdrawn, while three remained pending. The report also identified concerns about unclear standards for evaluating religious sincerity, the information petitioners were expected to provide, and the sometimes extraordinary length of time required for agency determinations. As of October 2026, GAO continues to list all four of its recommendations concerning DEA’s religious-exemption procedures as open.

Although federal RFRA is legally distinct from Washington’s constitutional protection of religious freedom, the report addresses questions strikingly similar to those we were litigating years earlier. What constitutes a sincere religious practice? How does the government assess religious beliefs that may not conform to familiar institutional structures? What burden may the government impose upon religious exercise, and how must it justify that burden? And what does religious freedom mean in practical terms if an individual or organization must spend years seeking permission to engage in the very practice for which legal protection is claimed?

These questions have increasingly attracted the attention of legal scholars, practitioners, and courts. In a 2024 law review article, Psychedelic Policy, Religious Freedom, and Public Safety: An Overview, published in the Ohio State Journal of Criminal Law, attorney and legal scholar Victoria Litman examined the uncertain legal position of religious communities using psychedelic substances. Litman drew an important distinction between religious practices that may be legally defensible and those that are affirmatively protected from prosecution. Her analysis raises a further public-policy question: whether continued criminal prohibition, uncertain enforcement, and the absence of accessible legal protections may themselves undermine the public-safety interests those laws are intended to serve.

More recently, Professor Elizabeth Sepper, writing in her September 2026 article, Psychedelic Churches in a Time of Religious Exemption, for the Yale Journal on Regulation, examined how evolving federal constitutional jurisprudence may open new avenues for challenging restrictions on the religious use of psychedelics. These developments are significant because federal RFRA, notwithstanding its application to certain controlled-substance exemptions, does not apply to state governments and cannot independently protect individuals from prosecution under Washington or other state controlled-substance laws. The federal First Amendment, however, does apply to the states, and recent Supreme Court decisions concerning religious exemptions and the government’s treatment of religious practices may provide additional grounds for constitutional challenges.

The continuing evolution of psychedelic law is also documented in Ronald W. McNutt’s September 2026 review, Clinical, Therapeutic, and Religious Uses of Psychedelics, which examines emerging psychedelic therapies, regulatory developments, and recent religious-freedom litigation. But developments in this area have not uniformly favored religious claimants. In its October 5, 2026 decision in Jensen v. Utah County, the Tenth Circuit rejected, at the preliminary-injunction stage, an argument that Utah’s allowance of psilocybin in limited medical settings required comparable accommodation of religious use under the federal Free Exercise Clause. The court also required the federal district court to abstain from interfering with an ongoing state criminal prosecution. The decision did not resolve the claimants’ separate protections under Utah’s own religious-freedom statute, illustrating the continuing importance of distinguishing federal statutory protections, federal constitutional guarantees, and independent state law.

The growing body of scholarship, legislative activity, and litigation reflects a legal landscape that is changing as scientific understanding develops and longstanding assumptions about psychedelic substances are reconsidered. But the fundamental questions concerning religious conscience, medical necessity, public safety, and the limits of criminal enforcement remain unresolved in important respects. The existence of a potentially meritorious defense does not necessarily provide meaningful protection against arrest and prosecution, and the expanding recognition of religious freedom in one jurisdiction does not automatically confer protection in another.

These are not merely abstract questions in constitutional theory. They concern the relationship between individual liberty, government authority, and the practical ability of people to exercise rights that the law purports to protect.